Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model (Q4687148): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Set OpenAlex properties. |
||
| (One intermediate revision by one other user not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1093/imammb/dqv007 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2032892681 / rank | |||
Normal rank | |||
Latest revision as of 23:01, 19 March 2024
scientific article; zbMATH DE number 6951505
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model |
scientific article; zbMATH DE number 6951505 |
Statements
Improving Bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model (English)
0 references
11 October 2018
0 references
mathematical modelling
0 references
bladder cancer
0 references
BCG immunotherapy
0 references
BCG and IL-2 combined therapy
0 references
immune system cells dynamics
0 references
